August 30, 2016 5:35 AM ET


Company Overview of Rexahn Pharmaceuticals, Inc.

Executive Profile

Peter C. Brandt

Chairman and Chairman of Nominating & Corporate Governance Committee, Rexahn Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 5 different industries.

See Board Relationships


Mr. Peter C. Brandt served as an Interim Chief Executive Officer and Interim President at Epocrates Inc. from November 16, 2011 to March 27, 2012. Mr. Brandt served as the President and Chief Executive Officer of Noven Pharmaceuticals Inc. since April 2008. He has extensive business and industry experience. He spent 28 years at Pfizer. He served as President - U.S. Pharmaceuticals Operations at Pfizer Inc., where he helped deliver revenue and earnings growth while engineering ...

Corporate Headquarters

15245 Shady Grove Road
Rockville, Maryland 20850

United States

Phone: 240-268-5300
Fax: 240-268-5310

Board Members Memberships

Member of The Board of Trustees
Chairman and Chairman of Nominating & Corporate Governance Committee


Columbia Business School
University of Connecticut

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$48,250
Total Calculated Compensation$78,016

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Rexahn Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at